Market Overview:
The global orthostatic hypotension market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of orthostatic hypotension, rising geriatric population, and technological advancements in the field of diagnostics. Based on type, the global orthostatic hypotension market is segmented into ECG, blood tests, stress test, and echocardiogram. The ECG segment is expected to account for the largest share of the global orthostatic hypotension market in 2018. This can be attributed to its high accuracy and easy availability. Based on application, the global orthostatic hypotension market is segmented into hospitals, clinics, ambulatory surgical centers (ASCs), and other applications such as research institutes and home care settings.
Product Definition:
Orthostatic hypotension is a condition where the blood pressure drops when you stand up. This can cause dizziness, lightheadedness, and fainting. Orthostatic hypotension is usually not serious but it can be a sign of other health problems.
ECG:
Orthostatic hypotension is caused by a decrease in blood pressure when the individual is standing still. It may also occur as a result of illness, drugs, aging or due to certain medical conditions such as heart disease and stroke. The normal range for systolic blood pressure (the top number in the tracing) is 120-80 mmHg and for diastolic blood pressure it's 80-60 mmHg.
Blood Tests:
Blood tests are used to diagnose and treat various medical conditions. The most common blood tests include a complete metabolic panel, thyroid test, HbA1c test (to measure average blood sugar level), HGB/HCT (measurement of the amount of hemoglobin in the red blood cells), BUN creatinine ratio (to determine kidney function) and electrolytes & liver panels.
Application Insights:
The primary application of the product is in hospitals, clinics and ambulatory surgical centers. The other applications include diagnostic laboratories and emergency services. Hospitals accounted for the largest share in 2015 owing to availability of advanced healthcare facilities along with a high prevalence of orthostatic hypotension due to conditions such as heart valve disease, stroke, kidney failure and cancer. In addition, rising awareness among patients about HTN is increasing the adoption rate among primary care physicians which further drives demand from this segment.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about orthostatic hypotension, favorable reimbursement scenario, and availability of advanced products and therapies in this region. Moreover, growing geriatric population and an increase in cardiovascular diseases are also contributing toward regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure with a rise in government initiatives for early diagnosis coupled with rising patient awareness levels regarding various conditions & treatments available for sale at affordable prices within this region that are not available outside it or unaffordable by most patients thus hampering treatment options for many chronic disorders including orthostatic hypotension (OHT). Availability of these low-cost treatment options would lead towards improved health outcomes thereby boosting demand over the projected time frame.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the orthostatic hypotension market growth in the coming years.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as hypertension, diabetes, and heart disease is rising rapidly across the globe and this is expected to increase the demand for orthostatic hypotension treatments in the near future.
- Growing awareness about orthostatic hypotension: There is growing awareness about orthostatic hypotension among people across the world due to increasing number of studies and research being conducted on it. This is likely to boost demand for Orthostatic Hypotension treatments in the coming years.
- Technological advancements in treatment options: There have been significant advancements in treatment options for Orthostatic Hypotension over recent years with introduction of new drugs and devices into marketplaces. This is likely to fuel market growth over next few years . 5) Availability of reimbursement policies: Reimbursement policies for Orthostatic Hypotension treatments are available in many countries worldwide which will help spur market growth during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Orthostatic Hypotension Market Research Report
By Type
ECG, Blood Tests, Stress Test, Echocardiogram
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
Mylan, Roche, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen, Apotex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Orthostatic Hypotension Market Report Segments:
The global Orthostatic Hypotension market is segmented on the basis of:
Types
ECG, Blood Tests, Stress Test, Echocardiogram
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- Roche
- Upsher-Smith Laboratories
- Chelsea Therapeutics
- Amgen
- Apotex
Highlights of The Orthostatic Hypotension Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ECG
- Blood Tests
- Stress Test
- Echocardiogram
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Orthostatic Hypotension Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Orthostatic hypotension is a condition in which blood pressure decreases when a person stands up after sitting or lying down. Orthostatic hypotension can be caused by many factors, including dehydration, low blood sugar levels, and medications.
Some of the key players operating in the orthostatic hypotension market are Mylan, Roche, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen, Apotex.
The orthostatic hypotension market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Orthostatic Hypotension Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Orthostatic Hypotension Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Orthostatic Hypotension Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Orthostatic Hypotension Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Orthostatic Hypotension Market Size & Forecast, 2020-2028
4.5.1 Orthostatic Hypotension Market Size and Y-o-Y Growth
4.5.2 Orthostatic Hypotension Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ECG
5.2.2 Blood Tests
5.2.3 Stress Test
5.2.4 Echocardiogram
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Orthostatic Hypotension Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Orthostatic Hypotension Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ECG
9.6.2 Blood Tests
9.6.3 Stress Test
9.6.4 Echocardiogram
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ECG
10.6.2 Blood Tests
10.6.3 Stress Test
10.6.4 Echocardiogram
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ECG
11.6.2 Blood Tests
11.6.3 Stress Test
11.6.4 Echocardiogram
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ECG
12.6.2 Blood Tests
12.6.3 Stress Test
12.6.4 Echocardiogram
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ECG
13.6.2 Blood Tests
13.6.3 Stress Test
13.6.4 Echocardiogram
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Orthostatic Hypotension Market: Competitive Dashboard
14.2 Global Orthostatic Hypotension Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 Roche
14.3.3 Upsher-Smith Laboratories
14.3.4 Chelsea Therapeutics
14.3.5 Amgen
14.3.6 Apotex
